<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Intensive Care Med Exp</journal-id><journal-id journal-id-type="iso-abbrev">Intensive Care Med Exp</journal-id><journal-title-group><journal-title>Intensive Care Medicine Experimental</journal-title></journal-title-group><issn pub-type="epub">2197-425X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4797870</article-id><article-id pub-id-type="publisher-id">948</article-id><article-id pub-id-type="doi">10.1186/2197-425X-3-S1-A808</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Hydrocortisone in treatment of severe sepsis and septic shock with acute respiratory distress syndrome: a randomised controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Tongyoo</surname><given-names>S</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Permpikul</surname><given-names>C</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Vattanavanit</surname><given-names>V</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Mongkolpun</surname><given-names>W</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Siriraj Hospital, Mahidol University, Critical Care Medicine, Bangkok, Thailand </aff><aff id="Aff2"><label/>Prince of Songkla University, Songkla, Thailand </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2015</year></pub-date><volume>3</volume><issue>Suppl 1</issue><issue-sponsor>The publication charges for this supplement were funded by Intensive Care Medicine Experimental.</issue-sponsor><elocation-id>A808</elocation-id><permissions><copyright-statement>&#x000a9; Tongyoo et al.; 2015</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><conference><conf-name>ESICM LIVES 2015</conf-name><conf-loc>Berlin, Germany</conf-loc><conf-date>3-7 October 2015</conf-date><string-conf><uri>http://www.esicm.org/</uri></string-conf></conference><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Severe sepsis and septic shock are serious conditions associated with high mortality, especially in the patients complicated with acute respiratory distress syndrome (ARDS). Corticosteroids are recommended in patients who do not respond to fluid resuscitation and vasopressors. However, efficacy of this treatment in severe sepsis patients with ARDS has not been investigated.</p></sec><sec id="Sec2"><title>Objectives</title><p>To examine efficacy of moderate dose of hydrocortisone in the treatment of severe sepsis/septic shock complicated with ARDS.</p></sec><sec id="Sec3"><title>Methods</title><p>A single center, placebo-controlled, randomized, double blind study which included adult patients with severe sepsis or septic shock and ARDS, onset within 24 hours. They were randomly assigned into two groups. The &#x0201c;study group&#x0201d; received hydrocortisone 50 mg intravenous every 6 hours for 7 days, while the &#x0201c;controlled group&#x0201d; received normal saline in the comparable volume. The primary outcome was 28 days mortality.</p></sec><sec id="Sec4"><title>Results</title><p>A total of 197 patients were included. Ninety eight were in &#x0201c;study group&#x0201d; and 99 were in the &#x0201c;control group&#x0201d;. While baseline characteristics were similar, the study group had longer organ support-free days in the 28 days (13.9+10.3 vs 10.8+10.1, P = 0.04), shorter vasopressor-dependent days (3.8+3.3 vs 5.2+5.7, P = 0.04), lower lung injury score at the 3<sup>rd</sup> day after treatment (1.5+0.8 vs 1.8+1.0, P = 0.03) and improve PaO<sub>2</sub>/FiO<sub>2</sub> ratio at the 3<sup>rd</sup> day after treatment (273.9+126.9 vs 227.6+110.3, P = 0.007). The incidence of hyperglycemia was also higher in the study group. Mortality in the study group was lower although statistical difference was not reached (25.5% vs 31.3%, P = 0.37).</p></sec><sec id="Sec5"><title>Conclusions</title><p>Hydrocortisone improved outcomes; namely organ support-free days, vasopressor-dependent days and oxygenation, in severe sepsis or septic shock patients with ARDS. There was a trend toward mortality reduction in the study group but the statistical significant was not reached. (ClinicalTrials.gov number, NCT01284452)</p></sec><sec id="Sec6"><title>Grant Acknowledgment</title><p>Facualty of Medicine, Siriraj Hospital, Mahidol University.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brower</surname><given-names>RB</given-names></name><name><surname>Pronovost</surname><given-names>JE</given-names></name><name><surname>Sevransky</surname><given-names>JS</given-names></name><name><surname>Martin</surname><given-names>G</given-names></name><name><surname>Mendez-Tellez</surname><given-names>PC</given-names></name></person-group><article-title>Mortality in sepsis versus non-sepsis induced acute lung injury</article-title><source>Crit Care</source><year>2009</year><volume>13</volume><fpage>1</fpage><lpage>6</lpage></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>BMC</given-names></name><name><surname>Craig</surname><given-names>J</given-names></name><name><surname>Eslick</surname><given-names>GD</given-names></name></person-group><article-title>Use of corticosteroids in acute lung injury and ARDS; A systematic reviews and meta-analysis</article-title><source>Crit Care Med</source><year>2009</year><volume>37</volume><fpage>1594</fpage><lpage>1602</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e31819fb507</pub-id><pub-id pub-id-type="pmid">19325471</pub-id></element-citation></ref></ref-list></back></article>